选择性自受体阻碍了抗瘤免疫力
Jiao Liu1, Rui Kang2, Daolin Tang2
1DAMP Laboratory, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510150, China.
Trends in cancer
|December 3, 2024
概括
与免疫相关的GTPase Q (IRGQ) 作为肝癌中的自受体,降解免疫抑制分子. 这一发现揭示了改善癌症免疫疗法有效性的新目标.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 自在癌症的发展和治疗中起着复杂的作用.
- 特定的自受体和货物选择对其功能至关重要.
- 免疫逃避是瘤使用生存治疗的关键机制.
研究的目的:
- 为了确定参与癌症的新型自受体.
- 研究IRGQ在肝细胞癌 (HCC) 中的作用.
- 探索IRGQ在免疫逃避中的机制及其治疗含义.
主要方法:
- 利用分子生物学技术来识别和表征自受体.
- 研究了IRGQ,自机械和向分子之间的相互作用.
- 在HCC模型中分析了IRGQ对免疫逃避的影响.
主要成果:
- 确定了与免疫相关的GTPase Q (IRGQ) 作为一种新的自受体.
- 证明IRGQ促进了组织相容性复合物I类 (MHC-I) 分子的降解.
- 表明IRGQ在肝细胞癌 (HCC) 中促进免疫逃避.
结论:
- 在HCC中,IRGQ是自介导免疫逃避的关键参与者.
- 准IRGQ可能是加强肝癌免疫治疗的策略.
- 对IRGQ作用的进一步研究可能会揭示新的治疗途径.
相关概念视频
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Delivery Pathways to the Lysosome
6.1K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


